APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $442,494,936 | -10.9% | 11,632,359 | +113.4% | 14.93% | +22.7% |
| Q2 2023 | $496,645,042 | +38.1% | 5,451,647 | 0.0% | 12.17% | +5.1% |
| Q1 2023 | $359,590,636 | +34.2% | 5,451,647 | +5.2% | 11.58% | +41.9% |
| Q4 2022 | $268,035,217 | -24.3% | 5,183,431 | 0.0% | 8.16% | -21.9% |
| Q3 2022 | $354,028,000 | +51.0% | 5,183,431 | 0.0% | 10.45% | +29.1% |
| Q2 2022 | $234,395,000 | -11.0% | 5,183,431 | 0.0% | 8.09% | -1.8% |
| Q1 2022 | $263,370,000 | +38.1% | 5,183,431 | +28.5% | 8.24% | +35.5% |
| Q4 2021 | $190,722,000 | +716.6% | 4,033,882 | +281.9% | 6.08% | +159.4% |
| Q1 2018 | $23,356,000 | -6.0% | 1,056,348 | -7.7% | 2.34% | -16.2% |
| Q4 2017 | $24,837,000 | – | 1,144,558 | – | 2.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |